Dr. Deepak P. Vivek, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 29
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,416
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
FL license ME92930 -
Cardiovascular Disease Physician
FL license ME92930
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Orlando Orlando, FL
- Orlando Health Orlando, FL
- Orlando Health South Lake Hospital Clermont, FL
- Orlando Health-Health Central Hospital Ocoee, FL
- Orlando Health St Cloud Hospital Saint Cloud, FL
Medical groups
- Orlando Health Medical Group Inc (2,287 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,416
- Services billed
- 4,261
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 702 | 445 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 431 | 183 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 335 | 329 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 309 | 271 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 274 | 248 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 271 | 137 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 176 | 166 |
| Ultrasound of heart, follow-up | 149 | 110 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 142 | 105 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 139 | 105 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Orlando, FL | 407 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Orlando, FL | 386 |
| Eliquis (apixaban) Other prescribers in Orlando, FL | 350 |
| Carvedilol Other prescribers in Orlando, FL | 323 |
| Amlodipine Besylate Other prescribers in Orlando, FL | 309 |
| Metoprolol Tartrate Other prescribers in Orlando, FL | 221 |
| Losartan Potassium Other prescribers in Orlando, FL | 215 |
| Metoprolol Succinate Other prescribers in Orlando, FL | 205 |
| Rosuvastatin Calcium Other prescribers in Orlando, FL | 191 |
| Lisinopril Other prescribers in Orlando, FL | 166 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 45 payments worth $2,599 in total to this clinician.
| Abbott Laboratories | $791 |
|---|---|
| Edwards Lifesciences Corporation | $469 |
| Medtronic, Inc. | $400 |
| Abiomed | $265 |
| Shockwave Medical, Inc | $241 |
| Heartflow, Inc. | $214 |
| Biosense Webster, Inc. | $112 |
| Philips North America LLC | $32.80 |
| Food and Beverage | $2,014 |
|---|---|
| Travel and Lodging | $584 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Abbott Laboratories Oct 13, 2025 | Travel and Lodging TENDYNE · Structural Heart · travel to Minnetonka, MN · in-kind | $513 |
| Abbott Laboratories Nov 25, 2025 | Travel and Lodging TENDYNE · Structural Heart · travel to Orlando, FL · in-kind | $61.90 |
| Abbott Laboratories Nov 25, 2025 | Travel and Lodging TENDYNE · Structural Heart · travel to Orlando, FL · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $23,820 in research payments for these studies, mostly to the institutions running them.
- EXPAND II
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.